Driehaus Capital Management LLC Amphastar Pharmaceuticals, Inc. Transaction History

Driehaus Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$19.46 - $25.28 $1.12 Million - $1.45 Million	-57,300 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.72 - $22.51 $1.02 Million - $1.29 Million	57,300 New	57,300 $1.14 Million
Q1 2018 May 15, 2018	SELL	$17.23 - $20.35 $205,071 - $242,205	-11,902 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$17.76 - $19.75 $211,379 - $235,064	11,902	11,902 $229,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.